In this 6-part Measles, Masterminds & Millions investigative report, it shows how the vaccine industry operates, delves into the lawsuits and new legislation reveals over 100 statistics the mainstream news doesn’t report, and breaks down how it’s ultimately being funded. The Clintons have played the long game in the vaccine industry, beginning with the free mandatory Vaccines for Children program back in 1994, and partnering with pharmaceutical manufacturers before, during, and after Hillary’s time as Secretary of State. Exceeding all of her rivals with big pharma donations during the 2016 presidential campaign, Merck alone has donated $250,000 – $500,000 to the Clinton Foundation. But it’s not just the Clintons, nor is it just Merck, the pharmaceutical industry has lobbied politicians on both sides of the fence for a long time, with pay-to-play schemes.
• In 2015 Big Pharma doled out $951,018 to 2016 presidential candidates, with Hillary Clinton toppling her rivals at $336,416, and Trump taking in just $1,010
• 2009 was the biggest Big Pharma lobbying year, totaling $272.8 million – coincidentally, during the Congressional debate for the Affordable Care Act
• In 2012, then-Secretary of State Hillary Clinton had a personal sit down with the CEO of Merck, later announcing a partnership spearheaded by Clinton, paid for by the State Department to the tune of $75 million, with matching funds from Norway, to reduce childbirth-related deaths in Africa
The Clintons, Big Pharma and Government Taking It To The Bank
In 2017 alone, tax-payers funded $4.3 billion in vaccines, in addition to funding any petitions that resulted in court fees and settlements. The vaccine manufacturers are not held accountable, side effects are swept under the rug in a silent federal settlement, and the government, liaisons, and manufacturers make bank off of citizens. Whereas they want everyone to believe vaccines are “safe” and those purporting otherwise are conspiracy theorists, their list of side effects is extensive, the reports coming in from individuals are in the hundreds of thousands, vaccine injury petitions increased 10% in 2017, and $4.1 billion has been paid out of the compensation program for injury and death claims since 1988.
It’s no secret how big pharma controls the industry, side-by-side with their cohorts. On March 20, 2017, President Trump called it out stating, “The cost of medicine in this country is outrageous.” He was explaining to people at a rally in Louisville, Kentucky how the same pills sold in the U.S. have far lower price tags in Europe. He went on to say, “You know why? Campaign contributions. Who knows, but somebody is getting very rich.”
Coincidentally, the very next day drug makers donated more money to political campaigns than they had on any other day in 2017 for the first half of the year. On March 21, 2017 eight pharmaceutical political action committees made 134 contributions to 77 politicians, totaling $279,400, that went to both Democrats and Republicans. Merck’s PAC led the way, donating $148,000 to 60 candidates that day, with then-House Speaker Paul Ryan receiving the highest in donations totaling $15,000. Some believe this was an attempt to pay off members of Congress to prevent an attack on their industry.
Whereas Merck spent $242,500 on campaign contributions and $3.7 million on lobbying in the first half of 2017, Pfizer’s PAC donated more than any pharmaceutical PAC in 2017, totaling $418,400.
To put this in perspective, even CNN reported correctly on big pharma contributions to presidential candidates in the 2016 presidential election. These numbers paint quite a picture. These funds don’t include how much corporations spend on lobbying Congress. Pfizer alone spent more than $10 million on lobbying in 2015. This chart indicates the amount of money each candidate received from big pharma through the end of 2015. Despite Hillary’s hard-core stance, she put on about prices being too high and how she was going to rectify this, they knew better, and more importantly – they thought she was going to win.
According to the Center for Responsive Politics, key lobbying players in 2014 focused on the patent system, research funding, and Medicare, hitting $229.1 million. That said, it shouldn’t come as a surprise that the industry’s record spending of $272.8 million was back in 2009 when the Affordable Care Act was being debated in Congress.